Causes & What We Know/September 8, 2026/2 min read

A New Way to Measure Type 1 Diabetes Genetic Risk Directly From Blood

Researchers have developed a simpler method to calculate genetic risk for Type 1 diabetes using blood serum alone. This advance could make risk screening more accessible and practical for identifying people at higher genetic risk.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

Scientists created a direct-from-serum method to calculate Type 1 diabetes genetic risk scores, meaning the test can be done using blood samples without additional processing steps
This approach simplifies the process of identifying genetic risk compared to previous methods, potentially making screening easier to perform and more widely available
The research was published in the Journal of Translational Medicine and represents progress in how we identify and understand genetic factors in Type 1 diabetes

Understanding Genetic Risk for Type 1 Diabetes

Type 1 diabetes has a strong genetic component. Certain genes and genetic variations make some people more likely to develop the condition than others. Identifying who carries these genetic risk factors has become an important part of understanding Type 1 diabetes and potentially identifying people who might benefit from prevention or early intervention studies.

However, calculating genetic risk has traditionally required multiple steps and specialized processing of blood samples. These barriers can make large-scale screening difficult and expensive.

A More Direct Approach to Risk Scoring

Researchers have now developed a direct-from-serum method for calculating Type 1 diabetes genetic risk scores. This means the risk calculation can be performed using serum—the liquid portion of blood—without requiring additional complex preparation steps.

By streamlining the process, this method makes it more practical to screen larger groups of people for genetic risk factors. Simpler methods mean faster results and lower costs, which can increase access to this type of screening.

What This Means for Research and Screening

This advancement in how we measure genetic risk could have several implications. It may make it easier for researchers to identify individuals at higher genetic risk for Type 1 diabetes, which could help with recruitment for prevention studies or long-term monitoring programs.

For families with a history of Type 1 diabetes, easier access to genetic risk screening could provide valuable information about which family members might benefit from closer monitoring or participation in research studies exploring ways to prevent or delay disease onset.

As with any genetic risk assessment, a positive result means increased likelihood but not certainty. Genetic risk is just one factor among many that influence whether someone will develop Type 1 diabetes.

Evidence label

Source: Journal of translational medicine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.